FDX1 and colorectal cancer: It was found that the mutation frequency of each regulator is relatively low, of which ATP7A showed the highest mutation rate, followed by ATP7B and LIPT1, while FDX1, CDKN2A, SLC31A1, and GCSH showed no mutation in all colorectal cancer tissues.